| pubmed-article:20122293 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20122293 | lifeskim:mentions | umls-concept:C0042769 | lld:lifeskim |
| pubmed-article:20122293 | lifeskim:mentions | umls-concept:C1101610 | lld:lifeskim |
| pubmed-article:20122293 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:20122293 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:20122293 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:20122293 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:20122293 | pubmed:dateCreated | 2010-3-31 | lld:pubmed |
| pubmed-article:20122293 | pubmed:abstractText | An inhibitor of microRNA-122 reduces viral load in chimpanzees that are chronically infected with hepatitis C virus, suggesting that such an approach might have therapeutic potential in humans. | lld:pubmed |
| pubmed-article:20122293 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20122293 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20122293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20122293 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20122293 | pubmed:issn | 1465-6914 | lld:pubmed |
| pubmed-article:20122293 | pubmed:author | pubmed-author:JoplingCather... | lld:pubmed |
| pubmed-article:20122293 | pubmed:author | pubmed-author:RobertsAshley... | lld:pubmed |
| pubmed-article:20122293 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20122293 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:20122293 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20122293 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20122293 | pubmed:pagination | 201 | lld:pubmed |
| pubmed-article:20122293 | pubmed:dateRevised | 2011-7-20 | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:meshHeading | pubmed-meshheading:20122293... | lld:pubmed |
| pubmed-article:20122293 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20122293 | pubmed:articleTitle | Targeting viral infection by microRNA inhibition. | lld:pubmed |
| pubmed-article:20122293 | pubmed:affiliation | School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK. | lld:pubmed |
| pubmed-article:20122293 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20122293 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:20122293 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20122293 | lld:pubmed |
